B10.09 Other human herpesvirus encephalitis

Name of the Condition

• Other human herpesvirus encephalitis

Summary

Other human herpesvirus encephalitis is a rare neurological condition characterized by inflammation of the brain parenchyma due to infection with herpesviruses other than herpes simplex virus (HSV). It typically presents with acute or subacute neurological symptoms, including altered mental status, fever, and focal deficits. The condition requires prompt medical evaluation to manage potential complications and guide treatment.

Causes

Other human herpesvirus encephalitis is caused by specific members of the Herpesviridae family, including cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). These viruses can invade the central nervous system, either through primary infection or reactivation of latent virus, leading to inflammation and tissue damage. Transmission routes vary by virus but may include direct contact with infected bodily fluids or respiratory droplets.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Advanced age, particularly for HHV-8-associated conditions.
• Congenital or perinatal exposure to cytomegalovirus.
• Close contact with individuals shedding the virus.

Symptoms

• Altered mental status, confusion, or disorientation.
• Fever and headache.
• Focal neurological deficits, such as weakness or sensory changes.
• Seizures or abnormal movements.
• Nausea, vomiting, or photophobia.

Diagnosis

Diagnosis involves a combination of clinical evaluation, neuroimaging (e.g., MRI or CT scans), and laboratory testing. Cerebrospinal fluid (CSF) analysis may show elevated white blood cells, protein, or viral DNA via PCR. Serological tests or viral culture can help identify the specific herpesvirus. Neuroimaging often reveals characteristic patterns of inflammation, such as temporal lobe involvement, though findings may vary by virus.

Treatment Options

Treatment typically includes antiviral therapy (e.g., ganciclovir, foscarnet) targeted at the specific herpesvirus, along with supportive care to manage symptoms (e.g., anticonvulsants for seizures, fever reduction). Corticosteroids may be used to reduce inflammation, especially in severe cases. Immunocompromised patients may require prolonged or adjusted therapy to prevent relapse.

Prognosis and Follow-Up

Prognosis depends on the virus involved, timeliness of treatment, and patient factors (e.g., immune status). Early intervention improves outcomes, but some patients may experience residual neurological deficits. Follow-up includes monitoring for symptom recurrence, cognitive or motor function, and potential complications. Long-term care may involve rehabilitation for persistent deficits.

Complications

• Permanent neurological damage (e.g., cognitive impairment, motor deficits).
• Seizure disorders.
• Increased intracranial pressure.
• Death in severe or untreated cases.

Lifestyle & Prevention

• Maintain good hygiene to reduce exposure to viral infections.
• Avoid close contact with individuals showing signs of herpesvirus infection (e.g., cold sores, shingles).
• For immunocompromised patients, follow medical advice to prevent reactivation (e.g., antiviral prophylaxis).
• Vaccinations (e.g., varicella) may reduce risk of related herpesvirus infections.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden neurological symptoms (e.g., confusion, seizures, severe headache) or signs of infection (e.g., fever, rash) with a history of herpesvirus exposure. Prompt evaluation is critical to prevent progression and complications.

Tips for Medical Coders

Code B10.09 is used for other human herpesvirus encephalitis, excluding herpes simplex virus (HSV) or varicella-zoster virus (VZV) encephalitis. Documentation should specify the causative herpesvirus (e.g., CMV, HHV-6) and confirm encephalitis (inflammation of brain parenchyma) to support coding. Ensure differentiation from other encephalitis codes (e.g., HSV-related) and verify no overlapping conditions are present.